Avidity Biosciences
RNA
#1877
Rank
C$14.88 B
Marketcap
C$98.79
Share price
0.00%
Change (1 day)
103.84%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: C$14.88 Billion

As of February 2026 Avidity Biosciences has a market cap of C$14.88 Billion. This makes Avidity Biosciences the world's 1877th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026C$14.88 B0.01%
2025C$14.88 B188.72%
2024C$5.15 B442.41%
2023C$0.95 B-52.51%
2022C$2.00 B40.87%
2021C$1.42 B16.34%
2020C$1.22 B

End of Day market cap according to different sources

On Jan 31st, 2026 the market cap of Avidity Biosciences was reported to be:

C$14.88 Billion
by Nasdaq info icon info icon
C$14.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Pfizer
PFE
C$204.64 B 1,274.82%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$141.96 B 853.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
C$2.90 B-80.51%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
C$8.25 B-44.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
C$0.18 B-98.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
C$1.11 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
C$14.88 B-0.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
C$4.06 B-72.68%๐Ÿ‡บ๐Ÿ‡ธ USA